Skip to main content

Table 5 Number of studies per meta-analysis, overall and broken down by outcome type, intervention comparison type and medical area

From: Characteristics of meta-analyses and their component studies in the Cochrane Database of Systematic Reviews: a cross-sectional, descriptive analysis

  

Meta-analyses

50%1

75%

90%

99%

Max

All

Total

22453

3

6

10

28

294

Data type

Dichotomous

14886

3

6

10

28

294

 

Continuous

6672

3

5

8

24

98

 

Mixed

895

4

7

12

46

133

Medical specialty

Cancer

905

5

8

14

43

69

 

Cardiovascular

1693

4

7

13

38

58

 

Central nervous system/musculoskeletal

1965

3

5

8

21

49

 

Digestive/endocr., nutritional and metabolic

2704

4

6

11

31

138

 

Gynaecology, pregnancy and birth

4656

3

5

8

20

76

 

Infectious diseases

965

3

5

9

27

63

 

Mental health and behavioural conditions

2918

3

5

10

30

174

 

Pathological conditions, symptoms and signs

701

3

6

10

31

294

 

Respiratory diseases

3021

3

5

8

20

39

 

Urogenital

1289

3

5

9

21

31

 

Other

1636

3

6

10

34

133

Interventions

Pharm. vs. Control/Placebo

8348

3

6

10

30

294

 

Pharm. vs. Pharm.

5571

3

6

10

28

174

 

Pharm. vs. Non-Pharm.

424

3

5

11

25

36

 

Non-Pharm. vs. Control/Placebo

4449

3

5

9

25

61

 

Non-Pharm. vs. Non-Pharm.

3661

3

5

9

28

58

Outcomes

Signs/symptoms reflecting continuation/end of condition

3639

3

5

9

29

110

 

Adverse events

2368

3

6

10

26

270

 

Infection/onset of new acute/chronic disease

2215

3

6

10

24

294

 

Biological markers

2071

3

6

10

28

138

 

General physical health

1921

3

5

9

27

58

 

Obstetric outcomes

1477

3

6

11

24

76

 

All-cause mortality

1278

4

8

13

36

75

 

Resource use/hospital stay/process

1187

3

5

9

27

99

 

Cause-specific mortality/major morbidity event/composite (mortality or morbidity)

920

4

6

11

34

133

 

Other outcomes (semi-objective)2

2044

3

6

11

30

174

 

Other outcomes (subjective)3

3239

3

5

9

23

69

  1. 1Minimum values and 25th percentiles are not listed, since these were identical across most meta-analysis types. The minimum value was 2 in all rows (noting that meta-analyses needed to contain at least 2 studies to be eligible for inclusion). The 25th percentile was 3 for Cancer and All-cause mortality, and 2 in every other row.
  2. 2Other outcomes (semi-objective): External structure, Internal structure, Surgical/device related success/failure, Withdrawals/drop-outs
  3. 3Other outcomes (subjective): Pain, Mental health outcomes, Quality of life/functioning, Consumption, Satisfaction with care, Composite (at least 1 non-mortality/morbidity)